Needham & Company LLC Begins Coverage on Alignment Healthcare (NASDAQ:ALHC)

Posted by Brian Himes on Oct 28th, 2026

Stock analysts at Needham & Company LLC started coverage on shares of Alignment Healthcare (NASDAQ:ALHC – Get Free Report) in a report issued on Wednesday, Briefing.com reports. The brokerage set a “hold” rating on the stock.

ALHC has been the subject of several other reports. Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Wall Street Zen lowered shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. UBS Group decreased their price objective on shares of Alignment Healthcare from $22.00 to $9.00 and set a “neutral” rating for the company in a research note on Monday, October 12th. TD Cowen decreased their price target on Alignment Healthcare from $21.00 to $12.00 and set a “buy” rating for the company in a research report on Monday, October 12th. Finally, Barclays cut their price objective on Alignment Healthcare from $16.00 to $10.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 6th. Seven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $15.91.

Read Our Latest Stock Report on Alignment Healthcare

Alignment Healthcare Price Performance

Shares of Alignment Healthcare stock opened at $8.05 on Wednesday. The stock’s 50-day moving average is $10.18 and its 200 day moving average is $17.02. Alignment Healthcare has a one year low of $6.01 and a one year high of $25.12. The firm has a market cap of $1.67 billion, a price-to-earnings ratio of 42.37 and a beta of 1.14.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.04. The company had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.31 billion. The business’s revenue was up 31.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.07 EPS. On average, sell-side analysts expect that Alignment Healthcare will post 0.14 EPS for the current fiscal year.

Insider Activity

In other Alignment Healthcare news, EVP Joseph S. Konowiecki sold 23,511 shares of the business’s stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $8.61, for a total value of $202,429.71. Following the completion of the transaction, the executive vice president owned 1,080,305 shares of the company’s stock, valued at $9,301,426.05. The trade was a 2.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO John E. Kao sold 27,400 shares of Alignment Healthcare stock in a transaction on Monday, September 14th. The stock was sold at an average price of $13.00, for a total transaction of $356,200.00. Following the sale, the chief executive officer directly owned 590,766 shares of the company’s stock, valued at $7,679,958. This represents a 4.43% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,061,967 shares of company stock worth $13,642,490. Insiders own 5.20% of the company’s stock.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in ALHC. VestGen Advisors LLC purchased a new stake in shares of Alignment Healthcare during the third quarter worth about $135,000. Park Avenue Securities LLC lifted its holdings in Alignment Healthcare by 37.2% in the third quarter. Park Avenue Securities LLC now owns 59,635 shares of the company’s stock worth $487,000 after buying an additional 16,157 shares during the period. Sterling Capital Management LLC raised its position in shares of Alignment Healthcare by 839.9% in the 3rd quarter. Sterling Capital Management LLC now owns 6,739 shares of the company’s stock worth $55,000 after acquiring an additional 6,022 shares in the last quarter. Yousif Capital Management LLC boosted its position in shares of Alignment Healthcare by 7.7% during the third quarter. Yousif Capital Management LLC now owns 48,187 shares of the company’s stock valued at $393,000 after purchasing an additional 3,444 shares in the last quarter. Finally, Assenagon Asset Management S.A. raised its holdings in Alignment Healthcare by 1,964.0% in the third quarter. Assenagon Asset Management S.A. now owns 822,164 shares of the company’s stock worth $6,709,000 after purchasing an additional 782,331 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

(Get Free Report)

Alignment Healthcare, Inc is a technology-enabled health insurance company focused on providing Medicare Advantage plans for seniors. The company combines health plan coverage with care coordination and clinical services designed to help members manage chronic conditions, access providers and navigate the health care system.

Its offerings include Medicare Advantage plans, supplemental benefits and member support services. Alignment also uses its proprietary technology platform, including the Alignment Virtual Application (AVA), to support care teams, analyze health information and help deliver more personalized services to members.

Founded in 2013, Alignment Healthcare serves Medicare-eligible consumers in selected markets, including California, Florida, Nevada and North Carolina.